Ascendis Pharma A/S

NASDAQ: ASND · Real-Time Price · USD
197.97
5.93 (3.09%)
At close: Aug 15, 2025, 3:59 PM
200.00
1.03%
After-hours: Aug 15, 2025, 06:18 PM EDT

Ascendis Pharma A/S Cash Flow Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-378.08M -481.45M -583.19M -383.58M
Depreciation & Amortization
17.71M 18.91M 17.96M 15.39M
Stock-Based Compensation
95.51M 66.66M 64.18M 66.83M
Other Working Capital
98.13M 7.09M 2.86M -7.33M
Other Non-Cash Items
60.98M 21M 18.6M -67.01M
Deferred Income Tax
4.84M 7.3M 5.38M -367K
Change in Working Capital
-107.16M -99.79M -18.62M -48.91M
Operating Cash Flow
-306.2M -467.36M -495.7M -417.65M
Capital Expenditures
-1.43M -2.44M -14.49M -24.23M
Cash Acquisitions
n/a 49.95K 9.36M -10.19M
Purchase of Investments
n/a n/a -213.84M -226.04M
Sales Maturities Of Investments
7.35M 288.87M 280.53M 149.88M
Other Investing Acitivies
950K 1.05K 171.73K -86.88M
Investing Cash Flow
6.88M 286.47M 61.73M -110.58M
Debt Repayment
122.79M 125.82M 496.93M -6.43M
Common Stock Repurchased
n/a -1.81M -105.31M -21.61M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
11.22M 8.47M 5.15M 11.54M
Financial Cash Flow
443.93M 134.29M 396.77M 351.39M
Net Cash Flow
167.38M -52.6M -1.5M -138.25M
Free Cash Flow
-307.62M -469.8M -510.19M -441.88M